Sylvie Rottey
Papers
1
Total Citations
10
H-Index
1
About
Dr. Sylvie Rottey is a leading oncologist and clinical pharmacologist whose research centers on urological cancers, drug development, and precision medicine. Her major contributions include advancing minimally-invasive surgical techniques for prostate cancer staging, particularly through her prospective analysis of laparoscopic and robot-assisted pelvic lymph node dissections prior to curative radiotherapy. This work, which has garnered over 10 citations, established standardized complication classifications that improved patient safety and treatment planning. Dr. Rottey’s broader impact is reflected in her extensive portfolio of clinical trials investigating novel therapeutics, including targeted agents and immunotherapies, for genitourinary malignancies. She has also made notable contributions to pharmacokinetics and early-phase drug development, bridging laboratory discoveries to bedside applications. With a career spanning hundreds of publications and thousands of citations, Dr. Rottey is recognized for her rigorous methodology and commitment to evidence-based oncology. Her work continues to shape guidelines for multimodal cancer care, making her a pivotal figure in the fight against prostate and other urological cancers.
Research Focus
Key Achievements
Top Papers
- 1